These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 8009483

  • 1. [Potassium channel openers. A new possible therapeutic principle in several diseases].
    Drottning P, Christensen H, Storstein L.
    Tidsskr Nor Laegeforen; 1994 Feb 10; 114(4):450-3. PubMed ID: 8009483
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS.
    J Cardiovasc Pharmacol; 1994 Feb 10; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [Abstract] [Full Text] [Related]

  • 3. [Ca-antagonist, K-channel-opener in the treatment of patients with congestive heart failure].
    Satoh K.
    Nihon Rinsho; 1993 May 10; 51(5):1293-8. PubMed ID: 8331797
    [Abstract] [Full Text] [Related]

  • 4. Potassium channel activator drugs: mechanism of action, pharmacological properties, and therapeutic potential.
    Longman SD, Hamilton TC.
    Med Res Rev; 1992 Mar 10; 12(2):73-148. PubMed ID: 1535674
    [No Abstract] [Full Text] [Related]

  • 5. ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease.
    Cavero I, Premmereur J.
    Cardiovasc Res; 1994 Jan 10; 28(1):32-3. PubMed ID: 8111790
    [No Abstract] [Full Text] [Related]

  • 6. [Potassium channel activators. Perspectives in the treatment of arterial hypertension].
    Giudicelli JF, Richer C, Berdeaux A.
    Presse Med; 1991 Jan 19; 20(2):75-81. PubMed ID: 1825708
    [Abstract] [Full Text] [Related]

  • 7. Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.
    Nagai H, Kitagaki K, Goto S, Suda H, Koda A.
    Jpn J Pharmacol; 1991 May 19; 56(1):13-21. PubMed ID: 1831870
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacology of potassium channel openers.
    Andersson KE.
    Pharmacol Toxicol; 1992 Apr 19; 70(4):244-54. PubMed ID: 1535127
    [Abstract] [Full Text] [Related]

  • 9. Cerebral vascular smooth muscle potassium channels and their possible role in the management of vasospasm.
    Zhang H, Cook D.
    Pharmacol Toxicol; 1994 Dec 19; 75(6):327-36. PubMed ID: 7899253
    [Abstract] [Full Text] [Related]

  • 10. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE.
    Dan Med Bull; 1996 Dec 19; 43(5):429-47. PubMed ID: 8960816
    [Abstract] [Full Text] [Related]

  • 11. Smooth muscle K+ channel openers; their pharmacology and clinical potential.
    Weston AH.
    Pflugers Arch; 1989 Dec 19; 414 Suppl 1():S99-105. PubMed ID: 2674897
    [No Abstract] [Full Text] [Related]

  • 12. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
    Longman SD, Clapham JC, Wilson C, Hamilton TC.
    J Cardiovasc Pharmacol; 1988 Dec 19; 12(5):535-42. PubMed ID: 2468052
    [Abstract] [Full Text] [Related]

  • 13. K(+)-channel openers: new antihypertensive drugs?
    Haeusler G.
    Clin Physiol Biochem; 1990 Dec 19; 8 Suppl 2():46-56. PubMed ID: 2095310
    [Abstract] [Full Text] [Related]

  • 14. Effects of pinacidil, cromakalim, and nicorandil on potassium currents of rat basilar artery smooth muscle.
    Zhang H, Stockbridge N, Weir B.
    Adv Exp Med Biol; 1991 Dec 19; 304():531-41. PubMed ID: 1839488
    [No Abstract] [Full Text] [Related]

  • 15. [Advance in pharmacology of potassium channels in cardiovascular system and their clinical use].
    Wu Y, Fang D.
    Zhonghua Yi Xue Za Zhi; 1992 Mar 19; 72(3):180-3. PubMed ID: 1319810
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of putative activators of K+ channels on pancreatic B-cell function.
    Plant TD, Garrino MG, Henquin JC.
    Pflugers Arch; 1989 Mar 19; 414 Suppl 1():S152-3. PubMed ID: 2528721
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of potassium channel openers and blockers in canine atrial muscle.
    Yanagisawa T, Hashimoto H, Taira N.
    Br J Pharmacol; 1989 Jul 19; 97(3):753-62. PubMed ID: 2527073
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle.
    Carr CS, Yellon DM.
    Basic Res Cardiol; 1997 Aug 19; 92(4):252-60. PubMed ID: 9342432
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.